Literature DB >> 30471400

Natural killer cell-mediated anticancer effects of an arabinogalactan derived from rice hull in CT26 colon cancer-bearing mice.

Li-Chan Yang1, Ching-Yi Lai2, Chang-Chi Hsieh3, Wen-Chuan Lin4.   

Abstract

Rice hull polysaccharides (RHPS) have been reported to activate innate immunity in mice. This study investigated the effects of RHPS on natural killer (NK) cell-mediated cytotoxicity in vitro and the possible underlying anticancer mechanisms in vivo. The results showed that sustained exposure to RHPS increased NK-92MI cell-mediated cytotoxicity in a time- and concentration-dependent manner. In addition, RHPS upregulated the expression of Fas ligand, TNF-related apoptosis-inducing ligand, perforin, and granzyme B of NK-92MI cells and induced the secretion of IFN-γ and TNF-α. In the in vivo experiment, colon cancer CT26-bearing mice were used to investigate the effects of RHPS in cytotoxicity and anticancer. The results revealed that RHPS inhibited cancer weight and volume in CT26-bearing mice and significantly upregulated splenic cytotoxicity and NK-cell population. Moreover, RHPS treatment increased NK-cell infiltration in tumors. Thus, RHPS can enhance NK-cell activation in vivo and in vitro, thereby exhibiting anticancer activity.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Anticancer; Arabinogalactan; Cytotoxicity; Natural killer cell; Polysaccharides; Rice hull

Mesh:

Substances:

Year:  2018        PMID: 30471400     DOI: 10.1016/j.ijbiomac.2018.11.200

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

Review 1.  Can Natural Products be Used to Overcome the Limitations of Colorectal Cancer Immunotherapy?

Authors:  Jiahuan Dong; Yufan Qian; Guangtao Zhang; Lu Lu; Shengan Zhang; Guang Ji; Aiguang Zhao; Hanchen Xu
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

2.  Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.

Authors:  Xiaodong Huang; Yujie Yang; Chao Yang; Huali Li; Huangrong Cheng; Yongbin Zheng
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.